PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells

Aiming for an adoptive natural killer (NK) cell therapy, we have developed a novel protocol to expand NK cells from peripheral blood. With this protocol using anti-human CD16 antibody and interleukin (IL)-2, NK (CD3(−)CD56(+)) cells could be expanded about 4000-fold with over 70% purity during a 21-...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yanan, Feng, Xiaoli, Jiang, Yang, Shi, Xiaoyun, Xing, Xiangling, Liu, Xiaoli, Li, Nailin, Fadeel, Bengt, Zheng, Chengyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217023/
https://www.ncbi.nlm.nih.gov/pubmed/27356741
http://dx.doi.org/10.18632/oncotarget.10235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217023/
https://www.ncbi.nlm.nih.gov/pubmed/27356741
http://dx.doi.org/10.18632/oncotarget.10235

Ejemplares similares